The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
A Novel Stereotactic Prostate Biopsy System Integrating Pre-Interventional Magnetic Resonance Imaging and Live Ultrasound Fusion
Abstract
PURPOSE: We developed an effective way to precisely diagnose prostate cancer using a novel prostate biopsy system that integrates pre-interventional magnetic resonance imaging with peri-interventional ultrasound for perineal navigated prostate biopsy. MATERIALS AND METHODS: A total of 106 men with findings suspicious for prostate cancer (median age 66 years, prostate specific antigen 8.0 ng/ml and prostate volume 47 ml) underwent multiparametric 3 Tesla magnetic resonance imaging. Suspicious lesions were marked and data were transferred to the novel biopsy system. Using a custom-made biplane transrectal ultrasound probe mounted on a stepper we gathered 3-dimensional ultrasound data and fused them with magnetic resonance imaging data. As a result, suspicious magnetic resonance imaging lesions were superimposed over the transrectal ultrasound data. Three-dimensional biopsy planning was done, including systematic biopsies. Perineal biopsies were taken under live ultrasound guidance and the precise site of each biopsy was documented in 3 dimensions. We evaluated feasibility, safety and cancer detection. RESULTS: Prostate cancer was detected in 63 of 106 patients (59.4%). Magnetic resonance imaging findings correlated positively with histopathology in 71 of 103 patients (68.9%). In magnetic resonance imaging lesions marked as highly suspicious, the detection rate was 95.8% (23 of 24 cases). Lesion targeted cores had a significantly higher positivity rate than nontargeted cores. The procedural targeting error of the first 2,461 biopsy cores was 1.7 mm. Regarding adverse effects, 2 patients experienced urinary retention and 1 had a perineal hematoma. Urinary tract infections did not develop. CONCLUSIONS: Perineal stereotactic prostate biopsies guided by the combination of magnetic resonance imaging and ultrasound enable effective examination of suspicious magnetic resonance imaging lesions. Each biopsy core taken is documented accurately for its location in 3 dimensions, enabling magnetic resonance imaging validation and tailored treatment planning. The morbidity of the procedure was minimal.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Xu, J., & Ward, E. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20073 · Cited by 12,596
Cited by
Image-Guided Prostate Biopsy Using Magnetic Resonance Imaging–Derived Targets: A Systematic Review
Moore, C. M., Robertson, N. L., Arsanious, N., Middleton, T., Villers, A., Klotz, L., Taneja, S. S., & Emberton, M. (2013) · European Urology · doi:10.1016/j.eururo.2012.06.004 · Cited by 535
Moore, C. M., Kasivisvanathan, V., Eggener, S., Emberton, M., Fütterer, J. J., Gill, I. S., Grubb III, R. L., Hadaschik, B., Klotz, L., Margolis, D. J. A., et al. (2013) · European Urology · doi:10.1016/j.eururo.2013.03.030 · Cited by 450
Self-citationWegelin, O., van Melick, H. H. E., Hooft, L., Bosch, J. L. H. R., Reitsma, H. B., Barentsz, J. O., & Somford, D. M. (2017) · European Urology · doi:10.1016/j.eururo.2016.07.041 · Cited by 425
Sonn, G. A., Chang, E., Natarajan, S., Margolis, D. J., Macairan, M., Lieu, P., Huang, J., Dorey, F. J., Reiter, R. E., & Marks, L. S. (2014) · European Urology · doi:10.1016/j.eururo.2013.03.025 · Cited by 371
Metadata
- Authors
- Hadaschik, B. A., Kuru, T. H., Tulea, C., Rieker, P., Popeneciu, I. V., Simpfendörfer, T., Huber, J., Zogal, P., Teber, D., Pahernik, S., Roethke, M., Zamecnik, P., Roth, W., Sakas, G., Schlemmer, H.-P., & Hohenfellner, M.
- Venue
- Journal of Urology
- Published
- 2011-12
- Volume
- 186
- Issue
- 6
- Pages
- 2214-2220
- ISSN
- 0022-5347 (ISSN-L)
- 1527-3792
- OpenAlex
- W2021535196
- Cited by
- 176
- References
- 1
- FWCI
- 20.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.